Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $0.64 in the prior trading day, Bioline Rx Ltd ADR (NASDAQ: BLRX) closed at $0.61, down -3.74%. In other words, the price has decreased by -$3.74 from its previous closing price. On the day, 0.76 million shares were traded. BLRX stock price reached its highest trading level at $0.6323 during the session, while it also had its lowest trading level at $0.5908.
Ratios:
Our goal is to gain a better understanding of BLRX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.47 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 0.88 whereas as Long-Term Debt/Eq ratio is at 0.60.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Maxim Group on May 18, 2017, Upgraded its rating to Buy and sets its target price to $3 from $1 previously.
On February 13, 2017, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $3.
Maxim Group Downgraded its Buy to Hold on August 12, 2016, whereas the target price for the stock was revised from $4 to $1.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLRX now has a Market Capitalization of 53949580 and an Enterprise Value of 634676160. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.21 while its Price-to-Book (P/B) ratio in mrq is 3.36. Its current Enterprise Value per Revenue stands at 132.224 whereas that against EBITDA is -15.05.
Stock Price History:
Over the past 52 weeks, BLRX has reached a high of $2.53, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is -41.12%, while the 200-Day Moving Average is calculated to be -57.05%.
Shares Statistics:
The stock has traded on average 432.67K shares per day over the past 3-months and 469390 shares per day over the last 10 days, according to various share statistics. A total of 79.94M shares are outstanding, with a floating share count of 79.50M. Insiders hold about 0.56% of the company’s shares, while institutions hold 1.60% stake in the company. Shares short for BLRX as of 1711584000 were 324649 with a Short Ratio of 1.37, compared to 1709164800 on 183915.
Earnings Estimates
The stock of Bioline Rx Ltd ADR (BLRX) is currently in the spotlight, with 1.0 analysts actively rating and assessing its market standing.On average, analysts expect EPS of -$0.29 for the current quarter, with a high estimate of -$0.29 and a low estimate of -$0.29, while EPS last year was -$0.15. The consensus estimate for the next quarter is -$0.29, with high estimates of -$0.29 and low estimates of -$0.29.
Analysts are recommending an EPS of between -$1.03 and -$1.03 for the fiscal current year, implying an average EPS of -$1.03. EPS for the following year is -$0.93, with 1.0 analysts recommending between -$0.93 and -$0.93.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $470k. There is a high estimate of $470k for the next quarter, whereas the lowest estimate is $470k.
A total of 2 analysts have provided revenue estimates for BLRX’s current fiscal year. The highest revenue estimate was $16.32M, while the lowest revenue estimate was $12.41M, resulting in an average revenue estimate of $14.36M. In the same quarter a year ago, actual revenue was $4.8MBased on 2 analysts’ estimates, the company’s revenue will be $27.77M in the next fiscal year. The high estimate is $34.34M and the low estimate is $21.2M.
